000			01537 a2200457 4500
005			20250513200135.0
264		0	_c20000120
008			200001s 0 0 eng d
022			_a0278-0240
024	7		_a10.1155/1999/278269 _2doi
040			_aNLM _beng _cNLM
100	1		_aBorg, A
245	0	0	_aBRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutations. _h[electronic resource]
260			_bDisease markers _cOct 1999
300			_a79-84 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAge of Onset
650	0	4	_aBreast Neoplasms _xepidemiology
650	0	4	_aDNA Mutational Analysis
650	0	4	_aFemale
650	0	4	_aFounder Effect
650	0	4	_aGenes, BRCA1
650	0	4	_aGenetic Predisposition to Disease
650	0	4	_aGenetic Testing
650	0	4	_aHumans
650	0	4	_aMiddle Aged
650	0	4	_aMutagenesis, Insertional
650	0	4	_aMutation
650	0	4	_aNeoplastic Syndromes, Hereditary _xepidemiology
650	0	4	_aNorway _xepidemiology
650	0	4	_aOvarian Neoplasms _xepidemiology
650	0	4	_aSequence Deletion
700	1		_aDørum, A
700	1		_aHeimdal, K
700	1		_aMaehle, L
700	1		_aHovig, E
700	1		_aMøller, P
773	0		_tDisease markers _gvol. 15 _gno. 1-3 _gp. 79-84
856	4	0	_uhttps://doi.org/10.1155/1999/278269 _zAvailable from publisher's website
999			_c10551330 _d10551330